An Overview of Thyroid Cancer Treatment Options

An Introduction to Thyroid Cancer Treatment

Thyroid cancer originates in the thyroid gland, a butterfly-shaped gland located at the base of the neck. While a cancer diagnosis is always serious, most types of thyroid cancer are highly treatable and often curable, particularly when diagnosed early.

The treatment strategy for thyroid cancer is highly individualized and depends on a number of key factors. These include the specific type of cancer (differentiated, which includes papillary and follicular; medullary; or anaplastic), the size of the tumor, its stage (whether it has spread to lymph nodes or distant parts of the body), and the patient’s age and overall health. For the vast majority of patients with differentiated thyroid cancer, the goal of treatment is curative. For rare, aggressive forms or very advanced disease, the goals shift to controlling the cancer’s growth and managing symptoms.

The Role of the Multidisciplinary Team

A coordinated, multidisciplinary team (MDT) approach is essential for providing comprehensive care for a patient with thyroid cancer. This team of specialists collaborates on diagnosis, treatment planning, and long-term follow-up.

Core members of a thyroid cancer MDT include:

• Endocrinologist: A physician who specializes in hormonal disorders. The endocrinologist is a key leader of the team, managing the patient’s thyroid hormone levels after surgery and overseeing long-term monitoring for recurrence.
• Endocrine Surgeon or Head and Neck Surgeon: A surgeon with specific expertise in operating on the thyroid gland. The skill of the surgeon is critical in safely removing the cancer while protecting important nearby structures.
• Nuclear Medicine Physician: A specialist who administers and manages radioactive iodine (RAI) therapy, an important treatment used after surgery for many patients.
• Medical Oncologist: A physician who manages systemic therapies, such as targeted therapy drugs, for the small number of patients with advanced or metastatic thyroid cancer.
• Pathologist: A physician who examines the thyroid tissue under a microscope to confirm the diagnosis, determine the exact type of cancer, and identify any aggressive features.
• Radiation Oncologist: A specialist who plans and delivers external beam radiation, which is used in specific situations.

Surgical Treatment: The Cornerstone of Therapy

For nearly all types of thyroid cancer, surgery is the first and most important treatment. The goal of the operation is to remove all of the cancerous tissue. The extent of the surgery depends on the tumor’s size, type, and whether it has spread.

• Total Thyroidectomy: This is the most common operation for thyroid cancer. The surgeon removes the entire thyroid gland. A total thyroidectomy is necessary for larger tumors, tumors that affect both lobes of the gland, or cancer that has spread to lymph nodes. Removing all thyroid tissue also makes it easier to monitor the patient for recurrence after surgery and makes subsequent radioactive iodine therapy more effective.
• Thyroid Lobectomy (or Hemithyroidectomy): This procedure involves removing only one of the two lobes of the thyroid gland—the one containing the tumor. A lobectomy may be an option for certain patients with small (typically under 4 cm), low-risk, well-differentiated tumors that are confined to one side of the gland with no evidence of spread. This approach preserves the function of the remaining lobe, and many patients may not need to take thyroid hormone medication afterward.
• Lymph Node Dissection (Neck Dissection): Differentiated thyroid cancer, particularly the papillary type, often spreads to the lymph nodes in the neck. If there is evidence of spread before or during the operation, the surgeon will remove the affected lymph nodes. A “central neck dissection” removes the nodes located in the center of the neck near the thyroid. A “lateral neck dissection” is a more extensive operation to remove nodes along the side of the neck.

The skill of the surgeon is paramount in thyroid surgery to avoid injury to two critical structures: the recurrent laryngeal nerves, which control the vocal cords, and the parathyroid glands, four tiny glands located behind the thyroid that regulate calcium levels in the body.

Radioactive Iodine (RAI) Therapy

Following a total thyroidectomy, many patients with differentiated thyroid cancer will receive a treatment called radioactive iodine (RAI) therapy. This therapy takes advantage of the unique fact that thyroid cells are the only cells in the body that actively absorb iodine.

RAI, usually given as a single pill, contains a radioactive form of iodine. When swallowed, it is absorbed into the bloodstream and travels throughout the body, where it is taken up and concentrated by any remaining thyroid cells, both normal and cancerous. The radiation emitted by the iodine then destroys these cells.

The purposes of RAI therapy are:

1. Ablation: To destroy any small remnants of normal thyroid tissue left behind after surgery. This “cleans the slate” and makes future monitoring more accurate.
2. Adjuvant Therapy: To treat any microscopic cancer cells that may have spread to lymph nodes or other parts of the body but are too small to have been seen or removed during surgery.

Not every patient needs RAI. It is generally recommended for patients with larger tumors, those whose cancer has spread to lymph nodes or distant sites, or those with more aggressive cancer subtypes. Patients with very small, low-risk cancers can often be cured with surgery alone.

Thyroid Hormone Suppression Therapy

After a total thyroidectomy, the body can no longer produce its own thyroid hormone. Therefore, patients must take a daily thyroid hormone replacement pill (levothyroxine) for the rest of their lives. This serves two purposes.

1. Replacement: It replaces the function of the thyroid gland, providing the hormone necessary for the body’s metabolism to function normally.
2. Therapy: The pituitary gland in the brain produces a hormone called TSH (Thyroid-Stimulating Hormone), which signals the thyroid to grow and produce hormone. TSH can also stimulate the growth of any remaining thyroid cancer cells. By giving a slightly higher dose of levothyroxine than the body needs, the pituitary gland senses that there is plenty of thyroid hormone and stops producing TSH. This leads to a low, or “suppressed,” TSH level in the blood, which helps to prevent the growth and recurrence of the cancer. The patient’s TSH level is carefully monitored by their endocrinologist to ensure it is low enough to be therapeutic but not so low that it causes side effects.

Systemic Therapies for Advanced Thyroid Cancer

For the small percentage of patients with advanced thyroid cancer that has spread to distant organs and is no longer responding to radioactive iodine therapy, systemic medications are used. Traditional chemotherapy is generally not effective. Instead, treatment relies on:

• Targeted Therapy (Kinase Inhibitors): These are oral medications that work by blocking specific proteins (kinases) and signaling pathways that cancer cells use to grow, divide, and form new blood vessels. Several different kinase inhibitors have been developed that are effective in slowing the progression of advanced differentiated and medullary thyroid cancers.
• External Beam Radiation Therapy (EBRT): This uses focused beams of radiation delivered from a machine outside the body. It is not a primary treatment for most thyroid cancers but can be very useful for treating specific metastatic spots that are causing symptoms, such as a painful bone metastasis. It is also a key component of treatment for the rare and highly aggressive anaplastic thyroid cancer.

Frequently Asked Questions

1. What is the most common treatment for thyroid cancer?
Surgery is the cornerstone and most common treatment for nearly all thyroid cancers. The most frequent operation is a total thyroidectomy, which is the complete removal of the thyroid gland. This is often followed by other treatments, such as radioactive iodine therapy and thyroid hormone suppression therapy.

2. Will I have to take medication for the rest of my life after thyroid surgery?
If you have a total thyroidectomy (removal of the entire thyroid gland), you will need to take a daily thyroid hormone replacement pill (levothyroxine) for the rest of your life. This replaces the hormone your thyroid used to make and is also a part of the cancer treatment to help prevent recurrence. If you only have a partial removal (a lobectomy), your remaining thyroid lobe may produce enough hormone on its own.

3. How does radioactive iodine (RAI) therapy work?
RAI therapy works by taking advantage of the thyroid gland’s natural need for iodine. Thyroid cells, including most thyroid cancer cells, absorb iodine from the blood. When a patient swallows a radioactive form of iodine, it is absorbed by any remaining thyroid or cancer cells, which are then destroyed by the radiation.

4. What is the difference between a thyroid lobectomy and a total thyroidectomy?
A thyroid lobectomy is the surgical removal of one of the two lobes of the thyroid gland. A total thyroidectomy is the removal of the entire gland. A lobectomy is a smaller operation that may be an option for very small, low-risk tumors, while a total thyroidectomy is the standard for larger or more advanced cancers.

5. Why is it important for the surgery to be performed by a high-volume surgeon?
The thyroid gland is located very close to critical structures. Two recurrent laryngeal nerves, which control the vocal cords, run directly behind the gland. Four tiny parathyroid glands, which control calcium, are also attached to the back of the thyroid. An experienced endocrine or head and neck surgeon who performs many thyroid operations is more skilled at preserving these structures, reducing the risk of complications like permanent voice changes or low calcium levels.

6. What is TSH suppression?
TSH, or Thyroid-Stimulating Hormone, is produced by the pituitary gland and can encourage the growth of thyroid cancer cells. TSH suppression is a therapeutic strategy where a patient takes a slightly higher dose of thyroid hormone medication than their body needs. This signals the pituitary to stop making TSH, which in turn helps to prevent any remaining cancer cells from growing.

7. Does everyone with thyroid cancer need radioactive iodine treatment?
No. Radioactive iodine (RAI) is an adjuvant therapy given after surgery to patients who are at a higher risk of recurrence. Patients with very small, low-risk cancers that are completely contained within the thyroid are often cured with surgery alone and do not require RAI. The decision is based on a careful evaluation of the final pathology report after surgery.